BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32221371)

  • 1. Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy.
    Vakili-Ghartavol R; Rezayat SM; Faridi-Majidi R; Sadri K; Jaafari MR
    Sci Rep; 2020 Mar; 10(1):5569. PubMed ID: 32221371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes.
    Vakili-Ghartavol R; Mehrabian A; Mirzavi F; Rezayat SM; Mashreghi M; Farhoudi L; Kharrazi S; Sadri K; Jaafari MR
    J Pharm Pharmacol; 2022 Sep; 74(9):1307-1319. PubMed ID: 35833585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
    da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
    J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study.
    Karimi M; Gheybi F; Zamani P; Mashreghi M; Golmohammadzadeh S; Darban SA; Badiee A; Jaafari MR
    Int J Pharm; 2020 Apr; 580():119211. PubMed ID: 32156530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma.
    Korani M; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Nanomedicine; 2019 Aug; 20():102013. PubMed ID: 31103736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages.
    Tran NP; Tran P; Yoo SY; Tangchang W; Lee S; Lee JY; Son HY; Park JS
    Biomater Adv; 2023 Nov; 154():213606. PubMed ID: 37678087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity.
    Pereira S; Egbu R; Jannati G; Al-Jamal WT
    Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
    Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
    J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
    Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
    J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
    Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy.
    Chen J; Ning E; Wang Z; Jing Z; Wei G; Wang X; Ma P
    Drug Deliv; 2021 Dec; 28(1):1389-1396. PubMed ID: 34180752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy.
    Lu X; Fang M; Yang Y; Dai Y; Xu J; Zhao D; Lu Y; Chen X; Lu S; Li N
    Drug Deliv Transl Res; 2020 Feb; 10(1):122-135. PubMed ID: 31444736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes.
    Kushwah V; Jain DK; Agrawal AK; Jain S
    Colloids Surf B Biointerfaces; 2018 Dec; 172():213-223. PubMed ID: 30172202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
    Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
    Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (L
    Su CY; Liu JJ; Ho YS; Huang YY; Chang VH; Liu DZ; Chen LC; Ho HO; Sheu MT
    Eur J Pharm Biopharm; 2018 Feb; 123():9-19. PubMed ID: 29154834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.